GlassScriptPhysician profile
Allen Darrell Probus
NPI 1043974710
$1,049.27
in general payments reported to CMS, 2019-2025
10 companies · $934 in 2025
The $934 reported for 2025 was more than what 86% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $99.86 · 2024: $15.11 · 2025: $934.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,049.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,049.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $365.94 | 2025 | Breztri, Airsupra, Tezspire |
| Insulet Corporation | $224.67 | 2025 | Omnipod |
| Radius Health, INC. | $131.58 | 2025 | Tymlos |
| Globus Medical, INC. | $129.47 | 2025 | Senza |
| Pfizer INC. | $77.87 | 2023 | |
| Tandem Diabetes Care, INC. | $41.66 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Hologic Sales and Service, LLC | $22.16 | 2025 | Aptima |
| Otsuka America Pharmaceutical, INC. | $21.99 | 2023 | Abilify Asimtufii, Rexulti |
| Xeris Pharmaceuticals, INC. | $18.82 | 2025 | Recorlev |
| Solventum Corporation | $15.11 | 2024 | Activ.A.C. |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allen Probus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.